Advanced Proteome Therapeutics Corporation
APTCF · OTC
4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $4 | $4 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $4 | $4 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.036 | -0.007 | -0.005 | -0.002 |
| % Growth | -426.1% | -30.2% | -178.9% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$0 |